Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07351240

The Acupuncture Treatment Effect in Patients With Schizophrenia

The Quality of Life of Acupuncture Treatment Effect in Patients With Schizophrenia

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Calo Psychiatric Center · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Among various psychiatric disorders, this study focuses specifically on patients with schizophrenia. The aim of this study is to evaluate the therapeutic effects of acupuncture on antipsychotic medication-related side effects and psychiatric symptoms in patients with schizophrenia. This is a single-blind randomized study. Participants will be randomly assigned to one of two groups: Neiguan and Shenmen. Both the Neiguan and Shenmen groups will receive acupuncture treatment twice weekly, with each session lasting 30 minutes, for a total of four consecutive weeks. Assessments will be conducted prior to acupuncture intervention and after each acupuncture session. All assessment data will be collected and analyzed using statistical methods including descriptive statistics, chi-square tests, and t-tests. Generalized Estimating Equations (GEE-I) and multiple linear regression analyses will be applied to examine differences in psychological health, quality of life, and happiness before and after acupuncture intervention. It is anticipated that acupuncture will reduce antipsychotic-related side effects, improve psychiatric symptoms in patients with schizophrenia, and subsequently enhance patients' quality of life and happiness.

Conditions

Interventions

TypeNameDescription
OTHERAcupunctureBoth the Neiguan and Shenmen groups will receive acupuncture treatment twice weekly, with each session lasting 30 minutes, for a total of four consecutive weeks. Assessments will be conducted prior to acupuncture intervention and after each acupuncture session.

Timeline

Start date
2025-12-16
Primary completion
2026-07-31
Completion
2026-09-30
First posted
2026-01-20
Last updated
2026-01-22

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT07351240. Inclusion in this directory is not an endorsement.